Company IRIDEX Corporation

Stocks

IRIX

US4626841013

Advanced Medical Equipment & Technology

Delayed Nasdaq 13:34:31 2026-10-20 EDT			5-day change	1st Jan Change
0.7773 ^USD	+0.95%		-8.37%	-31.82%

10-12	Iridex Says Glaucoma Therapy Lowers Eye Pressure, Reduces Medication Use	MT
10-12	Iridex Corporation Announces Publication of Two-Year Clinical Study Demonstrating Favorable Outcomes with Micropulse TLT in Patients with Early, Moderate, and Advanced Primary Glaucoma	CI

Business description: IRIDEX Corporation

IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

Number of employees: 93

Sales by Activity: IRIDEX Corporation

Fiscal Period: January	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Ophthalmology	53.9M	56.97M	51.87M	48.67M	52.68M

See all business segments

Geographical breakdown of sales: IRIDEX Corporation

Fiscal Period: January	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
United States	25.56M	29.18M	26.05M	22.69M	23.21M
Europe, Middle East and Africa	-	13.8M	13.52M	11.82M	14.39M
Asia/Pacific Rim	12.23M	10.93M	10.23M	11.95M	12.95M
Americas Excluding the U.S.	2.54M	3.06M	2.06M	2.2M	2.12M
Europe	13.57M	-	-	-	-

See all geographic segments

Executive Committee: IRIDEX Corporation

Manager	Title	Age	Since
Patrick Mercer CEO	Chief Executive Officer	54	2024-09-30
Romeo Dizon DFI	Director of Finance/CFO	68	2018-12-17
Philip Taylor IRC	Investor Relations Contact	-	-
Bassem BouHabib SAM	Sales & Marketing	50	2019-07-31
Mary Dy HRO	Human Resources Officer	-	-

See IRIDEX CORPORATION governance

Composition of the Board of Directors: IRIDEX Corporation

Director	Title	Age	Since
Scott Shuda CHM	Chairman	60	2020-06-23
Patrick Mercer BRD	Director/Board Member	54	2018-08-31
Beverly A. Huss BRD	Director/Board Member	66	2022-03-16
William Moore CHM	Chairman	77	2010-08-31
Yu-Hao Chen BRD	Director/Board Member	45	2025-03-18

Composition of the Board of Directors

Shareholders: IRIDEX Corporation

Name	Stocks	%	Valuation
Topcon Corp. 9.212 %	1,618,122	9.212 %	1 M $
Xinpo Venture Capital Co. Ltd. 6.757 %	1,186,809	6.757 %	747 690 $
Stanley Manne Trust 6.104 %	1,072,215	6.104 %	675 495 $
Paragon Associates 5.693 %	1,000,000	5.693 %	630 000 $
Brent Alexander Roland 5.021 %	881,998	5.021 %	555 659 $

List of IRIDEX CORPORATION shareholders

Company details: IRIDEX Corporation

IRIDEX Corp.

1212 Terra Bella Avenue

94043, Mountain View

http://www.iridex.com

Other Advanced Medical Equipment & Technology

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IRIDEX CORPORATION	+0.95%	-8.37%	-26.67%	-75.48%	13.52M
THERMO FISHER SCIENTIFIC, INC.	+1.54%	+4.01%	+26.81%	+48.51%	251B
DANAHER CORPORATION	+0.28%	+1.19%	+8.21%	+9.55%	158B
INTUITIVE SURGICAL, INC.	+1.21%	+3.73%	-4.51%	+64.03%	153B
BOSTON SCIENTIFIC CORPORATION	+1.01%	+4.85%	-54.83%	-9.27%	65.29B
SIEMENS HEALTHINEERS AG	+1.00%	+3.81%	-14.33%	-9.91%	51.23B
VEEVA SYSTEMS INC.	+0.02%	+6.67%	+12.54%	+60.57%	51.29B
EDWARDS LIFESCIENCES CORPORATION	+0.85%	+3.06%	+16.72%	+26.48%	50.27B
AGILENT TECHNOLOGIES, INC.	+2.33%	+1.30%	+21.56%	+59.14%	47.9B
WATERS CORPORATION	+2.76%	+3.97%	+30.03%	+75.93%	42.67B
Average	+1.17%	+0.25%	+1.55%	+24.95%	87.07B
Weighted average by Cap.	+1.13%	+2.64%	+7.84%	+37.77%